Antineoplastilised ravimid
Contracts total
11 591 568 €
Bids
2
Type
Supplies
Published
14.01.2026
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping antineoplastiliste ravimite ostmiseks Lisas 1 toodud kirjelduste alusel. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Awarded contracts
08.04.2026| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| L01AA09 Bendamustin | Apteegikaubanduse Hulgimüük OÜ | 30 867 € | 2 | 24.03.2026 |
| L01AD01 Carmustine | Apteegikaubanduse Hulgimüük OÜ | 52 572 € | 1 | 24.03.2026 |
| L01AB02 Treosulfan | Apteegikaubanduse Hulgimüük OÜ | 715 904 € | 1 | 24.03.2026 |
| L01BA04 Pemetrexed | TAMRO EESTI OÜ | 46 280 € | 2 | 31.03.2026 |
| L01CA04 Vinorelbine | Apteegikaubanduse Hulgimüük OÜ | 36 358 € | 2 | 24.03.2026 |
| L01CD04 Cabazitaxel | MAGNUM MEDICAL OÜ | 32 760 € | 2 | 24.03.2026 |
| L01DB01 Doksorubitsiinvesinikkloriid pegüleeritud liposomaalse vormina | AS Oribalt Tallinn | 17 407 € | 2 | 31.03.2026 |
| L01FF07 Dostarlimab | TAMRO EESTI OÜ | 396 031 € | 1 | 31.03.2026 |
| L01FX14 Polatuzumab-vedotiin | Roche Eesti Osaühing | 891 800 € | 1 | 26.03.2026 |
| L01FX14 Polatuzumab-vedotiin | Roche Eesti Osaühing | 191 100 € | 1 | 26.03.2026 |
| L01XD04 Aminolevulinic acid | Apteegikaubanduse Hulgimüük OÜ | 46 340 € | 1 | 24.03.2026 |
| L01FX24 Teklistamab | TAMRO EESTI OÜ | 35 305 € | 2 | 31.03.2026 |
| L01FX24 Teklistamab | MAGNUM MEDICAL OÜ | 899 962 € | 2 | 24.03.2026 |
| L01XC28 Durvalumab | MAGNUM MEDICAL OÜ | 2 075 307 € | 1 | 24.03.2026 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 4 515 225 € | 1 | 26.03.2026 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 42 140 € | 1 | 26.03.2026 |
| L01FF05 Atesolizumab | Roche Eesti Osaühing | 903 045 € | 1 | 26.03.2026 |
| L01FF06 Tsemiplimab | MAGNUM MEDICAL OÜ | 467 063 € | 1 | 24.03.2026 |
| L01XX24 Pegaspargaas | TAMRO EESTI OÜ | 60 528 € | 1 | 31.03.2026 |
| L02AE03 Goserelin | TAMRO EESTI OÜ | 24 570 € | 2 | 31.03.2026 |
| L02BA03 Fulvestrant | TAMRO EESTI OÜ | 58 968 € | 2 | 31.03.2026 |
| L03AX16 Plerixafor | MAGNUM MEDICAL OÜ | 52 036 € | 2 | 24.03.2026 |
Tender lots
25| Lot | Estimated value | Deadline |
|---|---|---|
| L01AA09 Bendamustin | 23.02.2026 | |
| L01AA07 Trofosamid | 23.02.2026 | |
| L01AD01 Carmustine | 23.02.2026 | |
| L01AB02 Treosulfan | 23.02.2026 | |
| L01BA01 Methotrexat | 23.02.2026 | |
| L01BA04 Pemetrexed | 23.02.2026 | |
| L01CA04 Vinorelbine | 23.02.2026 | |
| L01CD04 Cabazitaxel | 23.02.2026 | |
| L01DB01 Doksorubitsiinvesinikkloriid pegüleeritud liposomaalse vormina | 23.02.2026 | |
| L01DB06 Idarubicin | 23.02.2026 | |
| L01FF07 Dostarlimab | 23.02.2026 | |
| L01FX14 Polatuzumab-vedotiin | 23.02.2026 | |
| L01FX14 Polatuzumab-vedotiin | 23.02.2026 | |
| L01XD04 Aminolevulinic acid | 23.02.2026 | |
| L01FX24 Teklistamab | 23.02.2026 | |
| L01FX24 Teklistamab | 23.02.2026 | |
| L01XC28 Durvalumab | 23.02.2026 | |
| L01FF05 Atesolizumab | 23.02.2026 | |
| L01FF05 Atesolizumab | 23.02.2026 | |
| L01FF05 Atesolizumab | 23.02.2026 | |
| L01FF06 Tsemiplimab | 23.02.2026 | |
| L01XX24 Pegaspargaas | 23.02.2026 | |
| L02AE03 Goserelin | 23.02.2026 | |
| L02BA03 Fulvestrant | 23.02.2026 | |
| L03AX16 Plerixafor | 23.02.2026 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 3 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 3 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 4 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 6 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 10 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 10 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.